These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

655 related items for PubMed ID: 30955263

  • 1. [Dedifferentiated liposarcoma with inflammatory myofibroblastic tumor-like features: a clinicopathological analysis of five cases].
    Si HP, Wang Z, Fan QH, Zhang YF, Yang DQ, Zhang ZH, Gong QX.
    Zhonghua Bing Li Xue Za Zhi; 2019 Apr 08; 48(4):282-287. PubMed ID: 30955263
    [Abstract] [Full Text] [Related]

  • 2. [Retroperitoneal dedifferentiated liposarcoma with rhabdomyoblastic differentiation: a clinicopathological analysis].
    Liu L, Wang LH, Ren YB, Rao XS, Yang SM.
    Zhonghua Bing Li Xue Za Zhi; 2018 Feb 08; 47(2):94-98. PubMed ID: 29429159
    [Abstract] [Full Text] [Related]

  • 3. Dedifferentiated liposarcoma with inflammatory myofibroblastic tumor-like features.
    Lucas DR, Shukla A, Thomas DG, Patel RM, Kubat AJ, McHugh JB.
    Am J Surg Pathol; 2010 Jun 08; 34(6):844-51. PubMed ID: 20431481
    [Abstract] [Full Text] [Related]

  • 4. Correlation of histological grade of dedifferentiation with clinical outcome in 55 patients with dedifferentiated liposarcomas.
    Dantey K, Schoedel K, Yergiyev O, Bartlett D, Rao UNM.
    Hum Pathol; 2017 Aug 08; 66():86-92. PubMed ID: 28300575
    [Abstract] [Full Text] [Related]

  • 5. The utility of fluorescence in situ hybridization (FISH) in determining DNA damage-inducible transcript 3 (DDIT3) amplification in dedifferentiated liposarcomas - an important diagnostic pitfall.
    Kuczkiewicz-Siemion O, Wiśniewski P, Dansonka-Mieszkowska A, Grabowska-Kierył M, Olszewska K, Goryń T, Prochorec-Sobieszek M, Rutkowski P, Szumera-Ciećkiewicz A.
    Pathol Res Pract; 2021 Sep 08; 225():153555. PubMed ID: 34325315
    [Abstract] [Full Text] [Related]

  • 6. Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria.
    Mariño-Enríquez A, Fletcher CD, Dal Cin P, Hornick JL.
    Am J Surg Pathol; 2010 Aug 08; 34(8):1122-31. PubMed ID: 20588177
    [Abstract] [Full Text] [Related]

  • 7. [Well-differentiated/dedifferentiated liposarcoma associated with myxoid-like morphology: a clinicopathological and molecular genetic characteristics analysis of 34 cases].
    Xue S, Liu QY, Gou XN, Zhao YW, Cheng Q, Kong LF.
    Zhonghua Bing Li Xue Za Zhi; 2024 Feb 08; 53(2):168-173. PubMed ID: 38281785
    [Abstract] [Full Text] [Related]

  • 8. Differential diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: utility of p16 in combination with MDM2 and CDK4 immunohistochemistry.
    Kammerer-Jacquet SF, Thierry S, Cabillic F, Lannes M, Burtin F, Henno S, Dugay F, Bouzillé G, Rioux-Leclercq N, Belaud-Rotureau MA, Stock N.
    Hum Pathol; 2017 Jan 08; 59():34-40. PubMed ID: 27597521
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Retroperitoneal liposarcoma with combined well-differentiated and myxoid malignant fibrous histiocytoma-like myxoid areas.
    Hisaoka M, Morimitsu Y, Hashimoto H, Ishida T, Mukai H, Satoh H, Motoi T, Machinami R.
    Am J Surg Pathol; 1999 Dec 08; 23(12):1480-92. PubMed ID: 10584701
    [Abstract] [Full Text] [Related]

  • 11. Intraperitoneal dedifferentiated liposarcoma showing MDM2 amplification: case report.
    Grifasi C, Calogero A, Carlomagno N, Campione S, D'Armiento FP, Renda A.
    World J Surg Oncol; 2013 Nov 26; 11():305. PubMed ID: 24279301
    [Abstract] [Full Text] [Related]

  • 12. [Clinical value of fluorescence in situ hybridization with MDM2 and DDIT3 probe in diagnosis of liposarcoma].
    Wang W, Li X, Liu P, Dong Y.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr 18; 55(2):228-233. PubMed ID: 37042132
    [Abstract] [Full Text] [Related]

  • 13. Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?
    Le Guellec S, Chibon F, Ouali M, Perot G, Decouvelaere AV, Robin YM, Larousserie F, Terrier P, Coindre JM, Neuville A.
    Am J Surg Pathol; 2014 Mar 18; 38(3):293-304. PubMed ID: 24525499
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Paratesticular liposarcoma: the clinicopathological features of nineteen cases].
    Yang SM, Wu RC, Qi SS, You JF.
    Zhonghua Bing Li Xue Za Zhi; 2022 Jan 08; 51(1):17-22. PubMed ID: 34979748
    [Abstract] [Full Text] [Related]

  • 16. Dedifferentiated Liposarcoma With Epithelioid/Epithelial Features.
    Makise N, Yoshida A, Komiyama M, Nakatani F, Yonemori K, Kawai A, Fukayama M, Hiraoka N.
    Am J Surg Pathol; 2017 Nov 08; 41(11):1523-1531. PubMed ID: 28719466
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation.
    Henricks WH, Chu YC, Goldblum JR, Weiss SW.
    Am J Surg Pathol; 1997 Mar 08; 21(3):271-81. PubMed ID: 9060596
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.